Home › Pagkabigo ng Puso › Texas › Houston
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Houston, TX
Isang pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Nagre-recruitPhase 2/3
- Texas Children's Hospital ( Site 0039), Houston
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Nagre-recruit
- Baylor College of Medicine, Houston
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
- The Methodist Hospital Research Institute, Houston
Left vs Left Randomized Clinical Trial
Nagre-recruit
- Baylor College of Medicine, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Nagre-recruit
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Nagre-recruitObservasyonal na pag-aaral
- Houston, Houston
A Study of LY3971297 in Participants With Heart Failure
Nagre-recruitPhase 1
- Houston Methodist Hospital, Houston
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- at 3 pa
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Nagre-recruitPhase 3
- Texas Children's Hospital - Cardiology, Houston
Cardiogenic Shock Working Group Registry
Nagre-recruitObservasyonal na pag-aaral
- Houston Methodist Hospital, Houston
Assessment of CCM in HF With Higher Ejection Fraction
Nagre-recruit
- Baylor College of Medicine, Houston
- Houston Methodist, Houston
- Memorial Hermann Texas Medical Center, Houston
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- at 2 pa
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Nagre-recruitPhase 3
- Texas Children's Hospital - Cardiology, Houston
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Nagre-recruitPhase 2
- Local Institution - 19, Houston
- Local Institution - 20, Houston
- Local Institution - 21, Houston
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Nagre-recruitPhase 3
- Research Site, Houston
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Nagre-recruit
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Nagre-recruitPhase 2
- East Texas Cardiology PA, Houston
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Nagre-recruitPhase 3
- Research Site, Houston
- Research Site, Houston
- Research Site, Humble · 17 mi ang layo
BiVACOR® Total Artificial Heart Early Feasibility Study
Nagre-recruit
- Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Nagre-recruitPhase 3
- CON-10085, Houston, TX, Houston
- Houston, TX Investigative Site CON-10320, Houston
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Nagre-recruitPhase 3
- Houston, TX Investigative Site 10085, Houston
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
Nagre-recruitObservasyonal na pag-aaral
- Methodist DeBakey Heart and Vascular Center, Houston
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Nagre-recruitPhase 2
- Center for Advanced Heart Failure, Houston
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Nagre-recruitObservasyonal na pag-aaral
- Texas Children's Hospital, Houston
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Nagre-recruit
- Texas Heart Institute, Houston
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Nagre-recruitObservasyonal na pag-aaral
- The Methodist Hospital, Methodist Cancer Cencer, Houston
- BI Research Center, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- at 1 pa
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Nagre-recruitPhase 3
- FIN-10085, Houston, TX, Houston
18F-mFBG Imaging for Myocardial Sympathetic Innervation
Nagre-recruitPhase 2
- UT Health Houston, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Nagre-recruit
- Baylor/Texas Heart, Houston
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
Nagre-recruitObservasyonal na pag-aaral
- Baylor College of Medicine, Houston
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Houston Healthcare Medical Center, Houston
Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure
Nagre-recruitPhase 1
- Texas Heart Institute, Houston
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Nagre-recruitObservasyonal na pag-aaral
- Houston Methodist DeBakey Heart and Vascular Center, Houston
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY51 pag-aaral
- Boston, MA46 pag-aaral
- Dallas, TX42 pag-aaral
- Cleveland, OH31 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- Chicago, IL28 pag-aaral
- Durham, NC25 pag-aaral
- Kansas City, MO25 pag-aaral
- St. Louis, MO24 pag-aaral
- Indianapolis, IN24 pag-aaral
- Atlanta, GA23 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer143 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)124 pag-aaral
- Colorectal Cancer101 pag-aaral
- Metastatic Cancer100 pag-aaral
- Kanser sa Ovary90 pag-aaral
- Acute Myeloid Leukemia88 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate73 pag-aaral
- Kanser ng Endometrium69 pag-aaral
- Melanoma61 pag-aaral
- Kanser sa Pancreas59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.